From the *Royal Brompton and Harefield Hospitals, Part of Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
†University of Portsmouth, Portsmouth, United Kingdom
‡University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
§Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women’s Hospital, Brisbane, Australia
¶Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France
∥Imperial College London, London, United Kingdom
#King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.
Submitted for consideration February 2022; accepted for publication in revised form June 2022.
Disclosure: The authors have no conflicts of interest to report.
This study was funded in part by Merck Sharp and Dohme and a Galen award from Pharmacy Research UK.
J.A.R. would like to acknowledge funding from the Australian National Health and Medical Research Council for a Centre of Research Excellence (APP1099452) and a Practitioner Fellowship (APP1117065) as well as an Advancing Queensland Clinical Fellowship (Australia).
H.L., A.R., J.A.R., J.M., D.B., and A.S. have contributed to the conceptualization of the study. H.L. has collected data, performed statistical analyses, and contributed to formal analysis. H.L., D.B., J.M., J.A.R., A.S., and A.R. have contributed to data interpretation. All authors contributed to drafting and critical review of the manuscript, and approved the manuscript for submission.
Correspondence: Haifa Lyster, Royal Brompton & Harefield Hospitals, Part of Guy’s & St Thomas’ NHS Foundation Trust, London, UK. Email: [email protected]; Twitter: @HaifaLyster.
